Nasdaq

Tactile Medical Presents Promising Clinical Data for Flexitouch Plus in Treating Head and Neck Cancer-Related Lymphedema at ASCO 2025 Annual Meeting

Tactile Systems Technology, Inc. announced at the ASCO 2025 Annual Meeting new clinical data showing that its Flexitouch Plus device significantly improves clinical outcomes and quality of life for ...
Seeking Alpha

New Data Demonstrates Significant Clinical and Quality-of-Life Benefits of Flexitouch® Plus in Treating Lymphedema Among Head and Neck Cancer Survivors

MINNEAPOLIS, June 03, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the ...
Nasdaq

Tactile Systems (TCMD) Q2 Revenue Up 8%

Tactile Systems Technology develops and sells medical devices for patients with lymphedema, a condition causing swelling due to lymphatic system issues, and for those needing help with airway ...
Business Insider

Tactile Systems Technology, Inc. Reports Second Quarter 2018 Financial Results; Updates 2018 Outlook

Q2 Revenue Increased 30% Year-over-Year; Operating Income Up 80% MINNEAPOLIS, Minn., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical ...